Study
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study ID | Alternative Stable ID | Type |
---|---|---|
EGAS00001005437 | Other |
Study Description
This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (3) ABT414 + (TMZ|CCNU)
Study Datasets 3 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001007943 |
Intellance-2: rRNA-minus RNA-seq
|
Illumina NovaSeq 6000 | 224 |
EGAD00001007944 |
Intellance-2: TruSight Tumor 170 panel based RNA-seq
|
NextSeq 500 | 222 |
EGAD00001007945 |
Intellance-2: TruSight Tumor 170 panel based DNA-seq
|
NextSeq 500 | 216 |
Who archives the data?

Publications
Citations
Retrieving...

Retrieving...

Retrieving...

Retrieving...
